Company: PFSA
Filing Date: 2025-08-11
Form Type: PRE 14A
Source: 0001213900-25-073801
Chunk: 8

Company: Profusa, Inc.
Filing Date: 2025-08-11
Form: PRE 14A
Chunk 8
---
 voting rights. At the close of business on the record date for the Special Meeting, there were 32,788,877 shares of common stock outstanding, each of which entitles its holder to cast one vote per proposal. Proxies; Board Solicitation.Your proxy is being solicited by the Board on the proposals being presented to stockholders at the Special Meeting. Proxies may be solicited in person or by telephone. If you grant a proxy, you may still revoke your proxy and vote your shares online at the Special Meeting if you are a holder of record of the Company’s common stock. You may contact the Company at (212) 494 -9022. 5 PROPOSAL NO. 1: APPROVAL OF THE ELOC TRANSACTION General On July 28, 2025, we entered into the Securities Purchase Agreement (the “ Purchase Agreement”) with Ascent Partners Fund LLC (“ Ascent”), pursuant to which the Company may, from time to time and at its discretion, issue and sell to Ascent shares of the Company’s common stock for an aggregate purchase price of up to One Hundred Million Dollars ($100,000,000), subject to certain limitations and conditions. Also on July 28, 2025, we entered into a registration rights agreement with Ascent (the “ Registration Rights Agreement”), which we filed with the SEC as an exhibit to Form 8 -Kto register for resale under the Securities Act, the shares of common stock that have been or may be issued to Ascent under the Purchase Agreement. We are submitting this Proposal No. 1 to you in order to obtain the requisite stockholder authorization which would be required under Nasdaq Listing Rule 5635(d), if we sell shares of our common stock to Ascent in excess of 19.99% of our outstanding shares of common stock pursuant to the Purchase Agreement, as more fully described below. Overview of the Securities Purchase Agreement with Ascent Under the terms and subject to the conditions of the Purchase Agreement between the Company and Ascent, the Company has the right, but not the obligation, to sell to Ascent up to $100 million in shares of the Company’s common stock. These sales, if any, will be subject to certain limitations and may occur from time to time, at the Company’s sole discretion, during the period commencing on the effective date of the Purchase Agreement and ending on July 28, 2028, or such earlier date as the Purchase Agreement may be terminated in accordance with its terms (the “